Cite
HARVARD Citation
Chen, K. et al. (n.d.). FRI0307 LENABASUM, A CANNABINOID TYPE 2 RECEPTOR AGONIST, REDUCES CD4 CELL POPULATIONS AND DOWNREGULATES TYPE 1 AND 2 INTERFERON ACTIVITIES IN LESIONAL DERMATOMYOSITIS SKIN. Annals of the rheumatic diseases. p. 835. [Online].